While recovering from major surgery, Black patients may be less likely to receive certain multimodal analgesia options and ...

Keytruda's sBLA for LA-HNSCC treatment is under FDA priority review, with a decision expected by June 23. The KEYNOTE-689 trial showed significant improvements in event-free survival and major ...